- 全部删除
您的购物车当前为空
Clivatuzumab MMAE(克利妥珠单抗 MMAE)是一种ADC,由人源化抗MUC1(mucin)的单克隆抗体和抗有丝分裂的细胞毒素MMAE组成,用于胰腺癌的研究。
Clivatuzumab MMAE(克利妥珠单抗 MMAE)是一种ADC,由人源化抗MUC1(mucin)的单克隆抗体和抗有丝分裂的细胞毒素MMAE组成,用于胰腺癌的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 5,470 | In stock | |
| 5 mg | ¥ 10,800 | In stock | |
| 10 mg | ¥ 14,900 | In stock | |
| 25 mg | ¥ 21,900 | In stock |
Clivatuzumab MMAE 相关产品
| 产品描述 | Clivatuzumab MMAE is an ADC consisting of a humanized monoclonal antibody against MUC1 (mucin) and the anti-mitotic cytotoxin MMAE for pancreatic cancer. |
| 别名 | 克利妥珠单抗 MMAE |
| 分子量 | 145 kDa |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
评论内容